On the contrary, 17-β-estradiol-treated ERβKD cells gained more ability to cross the Matrigel, and tamoxifen could reverse the phenomenon, indicating that ERβ expression could lead to disabled invasiveness in NUGC-4 tumor cells (Figure 3E). Here, ESR2 is linked to neoplasm.